Antibody Trials
- All
- News
- Videos
-
New UCLA Therapy Shows Promise in Preventing Heart Failure After Heart Attacks
UCLA’s Broad Center researchers have developed an antibody therapy to help the heart heal after a heart attack. This therapy, which blocks the ENPP1 protein, reduces scar tissue formation that can lead to heart failure. Early tests showed that treated animals had less scarring and a reduced risk of severe heart failure. With plans for human trial...
-
New HIV Vaccine Candidate Shows Promise In Early Trials
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
-
This Japanese Company Is Working On World's First Drug To Grow New Teeth
The company is set to conduct clinical trials on healthy adults in July 2024 to verify the safety of its new drug.
-
Cancer Disappears From Every Patient's Body In Drug Trial In US: Report
A group of 12 rectal cancer patients showed no signs of a tumour after taking an antibody drug for six months, according to a surprise finding from an ongoing medical trial in the US that experts termed optimistic.
-
AstraZeneca, Given As Booster, Gives Higher Antibodies Against Omicron
AstraZeneca said on Thursday preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta, Delta, Alpha and Gamma, when given as a th
-
One Vaccine Makes More Antibodies Than Another. Does It Matter?
Ten months ago, the results of large clinical trials appeared almost too good to be true: Two messenger RNA vaccines reduced symptomatic Covid-19 cases by more than 90% in almost every group that got them.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
COVID-19 Antibody Discovered That Can Neutralise All Known SARS-CoV-2 Strains, Claim Researchers
Molecular Biology Consortium based at Berkeley Lab's Advanced Light Source (ALS) claims to have discovered an antibody that can neutralise all known SARS-CoV-2 strains, including the new mutants.
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
Antibody Drug Cuts Deaths From Some Severe Covid Patients: Study
A cocktail of synthetic antibodies reduces deaths among severe Covid patients who are unable to mount a strong immune response, results from a major clinical trial showed Wednesday.
-
2 COVID-19 Vaccines For Young Children Show Promise In Early Trials: Study
The Moderna COVID-19 vaccine and an experimental protein-based preventive proved to be safe and showed good antibody response against SARS-CoV-2 in a trial on baby rhesus macaques, scientists say.
-
Zydus Cadila Seeks Human Trial Approval For COVID-19 Antibody Cocktail
Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as India grapples with a shortage of medicines and vaccines needed to effectively tackle a devastating second wave of the pandemic.
-
Further Evaluation On Covaxin Shot Needed For Elderly, Children: Study
A COVID-19 vaccine developed by Bharat Biotech is safe and has shown high levels of antibody response in a mid-stage trial, but follow-on studies are needed to evaluate the shot for children and older people, a peer-reviewed study showed.
-
Haryana Health Minister Anil Vij Explains Why He Won't Take Covid Vaccine
As the second phase of the nationwide Covid vaccination began with Prime Minister Narendra Modi as the first beneficiary, Haryana Health Minister Anil Vij tweeted that he did not need the vaccine.
-
US Giant Merck Ends Covid Vaccine After Poor Response
Merck & Co. is discontinuing development of its two experimental Covid-19 vaccines after early trial data showed they failed to generate immune responses comparable to a natural infection or existing vaccines.
-
New UCLA Therapy Shows Promise in Preventing Heart Failure After Heart Attacks
UCLA’s Broad Center researchers have developed an antibody therapy to help the heart heal after a heart attack. This therapy, which blocks the ENPP1 protein, reduces scar tissue formation that can lead to heart failure. Early tests showed that treated animals had less scarring and a reduced risk of severe heart failure. With plans for human trial...
-
New HIV Vaccine Candidate Shows Promise In Early Trials
A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating broadly neutralizing antibodies and strong immune responses in 20 healthy participants.
-
This Japanese Company Is Working On World's First Drug To Grow New Teeth
The company is set to conduct clinical trials on healthy adults in July 2024 to verify the safety of its new drug.
-
Cancer Disappears From Every Patient's Body In Drug Trial In US: Report
A group of 12 rectal cancer patients showed no signs of a tumour after taking an antibody drug for six months, according to a surprise finding from an ongoing medical trial in the US that experts termed optimistic.
-
AstraZeneca, Given As Booster, Gives Higher Antibodies Against Omicron
AstraZeneca said on Thursday preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta, Delta, Alpha and Gamma, when given as a th
-
One Vaccine Makes More Antibodies Than Another. Does It Matter?
Ten months ago, the results of large clinical trials appeared almost too good to be true: Two messenger RNA vaccines reduced symptomatic Covid-19 cases by more than 90% in almost every group that got them.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
COVID-19 Antibody Discovered That Can Neutralise All Known SARS-CoV-2 Strains, Claim Researchers
Molecular Biology Consortium based at Berkeley Lab's Advanced Light Source (ALS) claims to have discovered an antibody that can neutralise all known SARS-CoV-2 strains, including the new mutants.
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
Antibody Drug Cuts Deaths From Some Severe Covid Patients: Study
A cocktail of synthetic antibodies reduces deaths among severe Covid patients who are unable to mount a strong immune response, results from a major clinical trial showed Wednesday.
-
2 COVID-19 Vaccines For Young Children Show Promise In Early Trials: Study
The Moderna COVID-19 vaccine and an experimental protein-based preventive proved to be safe and showed good antibody response against SARS-CoV-2 in a trial on baby rhesus macaques, scientists say.
-
Zydus Cadila Seeks Human Trial Approval For COVID-19 Antibody Cocktail
Zydus Cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild COVID-19, as India grapples with a shortage of medicines and vaccines needed to effectively tackle a devastating second wave of the pandemic.
-
Further Evaluation On Covaxin Shot Needed For Elderly, Children: Study
A COVID-19 vaccine developed by Bharat Biotech is safe and has shown high levels of antibody response in a mid-stage trial, but follow-on studies are needed to evaluate the shot for children and older people, a peer-reviewed study showed.
-
Haryana Health Minister Anil Vij Explains Why He Won't Take Covid Vaccine
As the second phase of the nationwide Covid vaccination began with Prime Minister Narendra Modi as the first beneficiary, Haryana Health Minister Anil Vij tweeted that he did not need the vaccine.
-
US Giant Merck Ends Covid Vaccine After Poor Response
Merck & Co. is discontinuing development of its two experimental Covid-19 vaccines after early trial data showed they failed to generate immune responses comparable to a natural infection or existing vaccines.
